Sharing Patent Costs. The Licensee shall reimburse NRC, promptly on the receipt of an invoice for twenty five per cent (25%) of NRC’s internal costs (to the extent reasonable) and disbursements related to obtaining and maintaining the Patents. This includes costs and disbursements incurred before this Agreement was in effect.
Appears in 4 contracts
Samples: Technology License Agreement (Helix BioPharma Corp), Technology License Agreement (Helix BioPharma Corp), Technology License Agreement (Helix BioPharma Corp)